Published in World J Cardiol on January 26, 2012
Heart rate differentiates urgency and emergency in hypertensive crisis. Clin Res Cardiol (2013) 0.83
Resting heart rate associates with one-year risk of major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention. Exp Biol Med (Maywood) (2015) 0.79
Resting heart rate in first year survivors of myocardial infarction and long-term mortality: a community study. Mayo Clin Proc (2014) 0.76
The relationship between heart rate and mortality of patients with acute coronary syndromes in the coronary intervention era: Meta-analysis. Medicine (Baltimore) (2016) 0.75
Stability and change of lifestyle profiles in cardiovascular patients after their first acute coronary event. PLoS One (2017) 0.75
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet (2010) 8.17
Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J (1987) 4.12
Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J (2005) 4.06
Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina. Eur Heart J (2005) 2.78
Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST). Eur Heart J (2008) 2.64
Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol (1980) 2.62
High heart rate: a risk factor for cardiovascular death in elderly men. Arch Intern Med (1999) 1.62
Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure. Circulation (2004) 1.55
Elevated heart rate: a major risk factor for cardiovascular disease. Clin Exp Hypertens (2005) 1.49
Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. Arch Intern Med (2002) 1.42
Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption. Circulation (2001) 1.37
Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol (1986) 1.33
Impact of increased heart rate on clinical outcomes in hypertension: implications for antihypertensive drug therapy. Drugs (2006) 1.30
Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization. Vasc Health Risk Manag (2010) 1.16
Role of parasympathetic inhibition in the hyperkinetic type of borderline hypertension. Circulation (1971) 1.15
Prevalence and prognostic influence of peripheral arterial disease in patients >or=40 years old admitted into hospital following an acute coronary event. Eur J Vasc Endovasc Surg (2008) 1.06
Does initial and delayed heart rate predict mortality in patients with acute coronary syndromes? Clin Cardiol (2004) 1.01
The effect of altering heart rate on ventricular function in patients with heart failure treated with beta-blockers. Am Heart J (2006) 0.91
Reduction of resting heart rate with antianginal drugs: review and meta-analysis. Am J Ther (2012) 0.86
Hemodynamic stress and experimental aortoiliac atherosclerosis. J Vasc Surg (1994) 0.86
Heart rate reduction induced by the if current inhibitor ivabradine improves diastolic function and attenuates cardiac tissue hypoxia. J Cardiovasc Pharmacol (2012) 0.84
Update on the medical treatment of stable angina. Arch Cardiovasc Dis (2011) 0.84
Increased heart rate and atherosclerosis: potential implications of ivabradine therapy. World J Cardiol (2011) 0.79
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43
Aorto-cavitary fistulous tract formation in infective endocarditis: clinical and echocardiographic features of 76 cases and risk factors for mortality. Eur Heart J (2004) 2.85
[Kinetics of C-reactive protein release in different forms of acute coronary syndrome]. Rev Esp Cardiol (2006) 2.23
[Corrected QT interval prolongation: a new predictor of cardiovascular risk in patients with non-ST-elevation acute coronary syndrome]. Rev Esp Cardiol (2008) 2.06
Morphology of far-field electrograms and antitachycardia pacing effectiveness among fast ventricular tachycardias occurring in ICD patients: a multicenter study. J Cardiovasc Electrophysiol (2013) 2.03
[An invasive strategy in non-ST-segment elevation acute coronary syndromes. From large trials to the real world]. Rev Esp Cardiol (2004) 2.03
New evidence, new controversies: a critical review of the European Society of Cardiology 2010 clinical practice guidelines on atrial fibrillation. Rev Esp Cardiol (Engl Ed) (2011) 2.01
[Prevalence of metabolic syndrome in the Spanish working population: MESYAS registry]. Rev Esp Cardiol (2005) 1.81
[Use of sirolimus-eluting stents in complex lesions: clinical and angiographic follow-up]. Rev Esp Cardiol (2004) 1.60
Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis: a transesophageal echocardiographic study. J Am Coll Cardiol (2003) 1.56
Validation of the SAMe-TT2R2 score in a nationwide population of nonvalvular atrial fibrillation patients on vitamin K antagonists. Thromb Haemost (2015) 1.49
Erectile dysfunction in high-risk hypertensive patients treated with beta-blockade agents. Cardiovasc Ther (2010) 1.48
[Emergency room risk stratification of patients with chest pain without ST segment elevation]. Rev Esp Cardiol (2003) 1.46
Impact of new criteria for anticoagulant treatment in atrial fibrillation. Rev Esp Cardiol (2011) 1.44
Relationship between metabolic syndrome and ischemic heart disease mortality in Spain. Rev Esp Cardiol (2009) 1.44
[Treatment of acute myocardial infarction by primary angioplasty on-site compared with treatment following interhospital transfer: short- and long-time clinical outcomes]. Rev Esp Cardiol (2007) 1.41
[Myocardial echocardiography with intracoronary injection of contrast in post-infarction patients. Implications and comparison with angiography and magnetic resonance imaging]. Rev Esp Cardiol (2004) 1.40
Early reduction of QT dispersion after primary percutaneous intervention in ST-segment elevation acute myocardial infarction. Mechanisms and clinical implications. Cardiology (2009) 1.40
Association between renal function and cardiovascular disease in patients with left ventricular hypertrophy. VIIDA study. J Clin Hypertens (Greenwich) (2009) 1.40
[Sex differences in mortality at one-month and at one-year after an acute coronary syndrome]. Med Clin (Barc) (2004) 1.39
Homocysteine and outcome in young patients with acute coronary syndromes. Int J Cardiol (2006) 1.39
Alternative explanations to the differences of femoral and brachial saline contrast injections for echocardiographic detection of patent foramen ovale. Med Hypotheses (2006) 1.39
[Plasma concentration of big endothelin-1 and its relation with plasma NT-proBNP and ventricular function in heart failure patients]. Rev Esp Cardiol (2005) 1.38
[Impact of blood pressure control on the ankle-brachial index in hypertensive patients]. Med Clin (Barc) (2012) 1.38
Blood pressure control in hypertensive women aged 65 years or older in a primary care setting. MERICAP study. Rev Esp Cardiol (2011) 1.38
Implantation of single-lead atrioventricular permanent pacemakers guided by electroanatomic navigation without the use of fluoroscopy. Europace (2008) 1.30
Multicenter randomized trial of a comprehensive hospital discharge and outpatient heart failure management program. Eur J Heart Fail (2004) 1.21
Characteristics and outcome of acute myocardial infarction in young patients. The PRIAMHO II study. Cardiology (2006) 1.13
Periannular complications in infective endocarditis involving prosthetic aortic valves. Am J Cardiol (2006) 1.11
Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur Heart J (2003) 1.10
Ischemia Modified Albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T. Int J Cardiol (2004) 1.09
Association between self-replicating calcifying nanoparticles and aortic stenosis: a possible link to valve calcification. Eur Heart J (2008) 1.08
Multiple complex stenoses, high neutrophil count and C-reactive protein levels in patients with chronic stable angina. Atherosclerosis (2004) 1.04
Periannular complications in infective endocarditis involving native aortic valves. Am J Cardiol (2006) 0.99
Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectoris. Eur Heart J (2005) 0.97
Usefulness of an abnormal ankle-brachial index for detecting multivessel coronary disease in patients with acute coronary syndrome. Rev Esp Cardiol (2010) 0.95
Ischemia-modified albumin concentrations in patients with peripheral vascular disease and exercise-induced skeletal muscle ischemia. Clin Chem (2004) 0.93
Obese subjects with heart failure have lower N-terminal pro-brain natriuretic peptide plasma levels irrespective of aetiology. Eur J Heart Fail (2005) 0.91
Predictive value of coronary artery stenoses and C-reactive protein levels in patients with stable coronary artery disease. Atherosclerosis (2008) 0.91
Identification of serum endoglin as a novel prognostic marker after acute myocardial infarction. J Cell Mol Med (2008) 0.90
Long-term mortality and hospital readmission after acute myocardial infarction: an eight-year follow-up study. Rev Esp Cardiol (Engl Ed) (2011) 0.90
Neutrophil count and infarct size in patients with acute myocardial infarction. Int J Cardiol (2004) 0.90
Comparison of ischemia-modified albumin levels in patients undergoing percutaneous coronary intervention for unstable angina pectoris with versus without coronary collaterals. Am J Cardiol (2004) 0.90
Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up. J Thorac Cardiovasc Surg (2006) 0.90
Influence of cycle length variations on antitachycardia pacing effectiveness among ICD patients. Heart Rhythm (2012) 0.90
[ESH/ESC 2007 Guidelines for the management of arterial hypertension]. Rev Esp Cardiol (2007) 0.90
[Prognostic value of Charlson comorbidity index at 30 days and 1 year after acute myocardial infarction]. Rev Esp Cardiol (2004) 0.90
Consensus document for the detection and management of chronic kidney disease. Nefrologia (2014) 0.88
Pseudoaneurysm complicating aortic coarctation in a pregnant woman. Int J Cardiol (2004) 0.88
[Aldosterone receptor antagonist use after myocardial infarction. Data from the REICIAM registry]. Rev Esp Cardiol (2011) 0.88
Prognostic value of low ankle-brachial index in patients with hypertension and acute coronary syndromes. J Hypertens (2009) 0.87
[Acute myocardial infarction in patients under 45 years]. Rev Esp Cardiol (2002) 0.87
Obese and nonobese patients with essential hypertension show similar N-terminal proBNP plasma levels. Am J Hypertens (2008) 0.86
Usefulness of a comprehensive cardiovascular magnetic resonance imaging assessment for predicting recovery of left ventricular wall motion in the setting of myocardial stunning. J Am Coll Cardiol (2005) 0.86
Low lymphocyte count in acute phase of ST-segment elevation myocardial infarction predicts long-term recurrent myocardial infarction. Coron Artery Dis (2010) 0.86
Variability of NT-proBNP plasma and urine levels in patients with stable heart failure: a 2-year follow-up study. Heart (2007) 0.86
Prognostic usefulness of white blood cell count on admission and one-year outcome in patients with non-ST-segment elevation acute chest pain. Am J Cardiol (2006) 0.86
Short- and long-term results of a programme for the prevention of readmissions and mortality in patients with heart failure: are effects maintained after stopping the programme? Eur J Heart Fail (2005) 0.85
Prognostic value of neopterin levels in treated patients with hypertension and chest pain but without obstructive coronary artery disease. Am J Cardiol (2004) 0.85
Complete regression of cardiac non-Hodgkin lymphoma. Int J Cardiol (2006) 0.84
Combination of ankle brachial index and diabetes mellitus to predict cardiovascular events and mortality after an acute coronary syndrome. Int J Cardiol (2010) 0.84
Effect of direct-current cardioversion on ischemia-modified albumin levels in patients with atrial fibrillation. Am J Cardiol (2004) 0.84
Impact of clinical and subclinical peripheral arterial disease in mid-term prognosis of patients with acute coronary syndrome. Am J Cardiol (2009) 0.84
A comparative study of markers of inflammation for the assessment of cardiovascular risk in patients presenting to the emergency department with acute chest pain suggestive of acute coronary syndrome. Int J Cardiol (2005) 0.84
Inflammation and apoptosis in hypertension. Relevance of the extent of target organ damage. Rev Esp Cardiol (Engl Ed) (2012) 0.83
Usefulness of the fractional flow reserve derived by intracoronary pressure wire for evaluating angiographically intermediate lesions in acute coronary syndrome. Rev Esp Cardiol (2010) 0.83
Diagnostic and prognostic value of urine NT-proBNP levels in heart failure patients. Eur J Heart Fail (2006) 0.83
Differences in medical treatment of chronic coronary heart disease patients according to medical specialities. Cardiovasc Ther (2009) 0.83
Variability of NT-proBNP and its relationship with inflammatory status in patients with stable essential hypertension: a 2-year follow-up study. PLoS One (2012) 0.83